Sab Biotherapeutics, Inc. · NASDAQ:SABS

Ra Capital Management, L.P. reported a 9.90% stake in Sab Biotherapeutics, Inc. (Schedule 13D)

Event Sep 26, 2025 · Filed Oct 3, 2025

Ra Capital Management, L.P. reported a 9.90% stake in Sab Biotherapeutics, Inc., 4,401,500 shares, with active intent on Sep 26, 2025. Filed Oct 3, 2025 (Schedule 13D).

Stake
9.90%
Shares
4,401,500
Intent
Active
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%4,401,500
Peter Kolchinsky9.90%4,401,500
Rajeev Shah9.90%4,401,500
RA Capital Healthcare Fund, L.P.9.90%4,401,500

Source

View original at SEC

Related